MARKER THERAPEUTICS, INC - 48 Year Dividend History | MRKR

Historical dividend payout and yield for MARKER THERAPEUTICS, INC (MRKR) since 1971. The current TTM dividend payout for MARKER THERAPEUTICS, INC (MRKR) as of October 18, 2019 is $0.00. The current dividend yield for MARKER THERAPEUTICS, INC as of October 18, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.190B $0.000B
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company specializing in the development of innovative peptide and nucleic acid-based immunotherapeutic vaccines for the treatment and eradication of cancer, including metastatic cancer. The company's product pipeline consists of MultiTAA T Cell Therapy, TPIV200 and TPIV100/110 which are in clinical stage. Marker Therapeutics Inc., formerly known as TapImmune Inc., is based in FL, United States.
Stock Name Country Market Cap PE Ratio